Javier García‐Pérez

2.2k total citations
42 papers, 1.1k citations indexed

About

Javier García‐Pérez is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Javier García‐Pérez has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 22 papers in Infectious Diseases and 11 papers in Immunology. Recurrent topics in Javier García‐Pérez's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Javier García‐Pérez is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Javier García‐Pérez collaborates with scholars based in Spain, France and United States. Javier García‐Pérez's co-authors include José Alcamı́, Juan F. Navarro‐González, Carmen Mora‐Fernández, Bernard Lagane, Fernando Arenzana‐Seisdedos, Esther Kellenberger, Mayte Pérez‐Olmeda, José M. Almendral, Juan Camilo Ramírez and Eleuterio Lombardo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Javier García‐Pérez

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier García‐Pérez Spain 18 444 372 283 269 129 42 1.1k
Greg Bristol United States 15 564 1.3× 273 0.7× 478 1.7× 451 1.7× 168 1.3× 19 1.3k
Meritxell Genescà Spain 19 475 1.1× 221 0.6× 456 1.6× 175 0.7× 198 1.5× 40 1.0k
Olivier Delézay France 20 411 0.9× 214 0.6× 367 1.3× 440 1.6× 163 1.3× 39 1.2k
Kyoko Sakai Japan 18 373 0.8× 223 0.6× 379 1.3× 267 1.0× 329 2.6× 44 1.4k
Alicja Wiercińska‐Drapało Poland 17 232 0.5× 334 0.9× 150 0.5× 344 1.3× 459 3.6× 119 1.3k
Greg LaRosa United States 7 513 1.2× 216 0.6× 675 2.4× 322 1.2× 147 1.1× 10 1.2k
Barbara Varano Italy 20 416 0.9× 192 0.5× 894 3.2× 291 1.1× 255 2.0× 40 1.4k
Tanja Werner Germany 16 64 0.1× 153 0.4× 318 1.1× 273 1.0× 142 1.1× 39 923
Sonia Zicari United States 17 309 0.7× 310 0.8× 256 0.9× 375 1.4× 219 1.7× 34 1.1k

Countries citing papers authored by Javier García‐Pérez

Since Specialization
Citations

This map shows the geographic impact of Javier García‐Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier García‐Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier García‐Pérez more than expected).

Fields of papers citing papers by Javier García‐Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier García‐Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier García‐Pérez. The network helps show where Javier García‐Pérez may publish in the future.

Co-authorship network of co-authors of Javier García‐Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier García‐Pérez. A scholar is included among the top collaborators of Javier García‐Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier García‐Pérez. Javier García‐Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez-Mora, Sara, Magdalena Corona, Elena Mateos, et al.. (2023). Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19. Cancers. 15(20). 5066–5066. 1 indexed citations
2.
García‐Pérez, Javier, Mercedes Bermejo, Erick De La Torre Tarazona, et al.. (2023). Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern. Journal of Medical Virology. 95(3). e28679–e28679. 3 indexed citations
3.
Herrera, Carolina, Mackenzie L. Cottrell, Angela D. M. Kashuba, et al.. (2022). The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans. iScience. 25(6). 104409–104409. 3 indexed citations
4.
Torres, Montserrat, Magdalena Corona, Sara Rodríguez-Mora, et al.. (2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 14(22). 5537–5537. 1 indexed citations
5.
Rodríguez-Mora, Sara, Magdalena Corona, Montserrat Torres, et al.. (2022). Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. Journal of Clinical Medicine. 11(10). 2803–2803. 5 indexed citations
6.
Rodríguez-Mora, Sara, Javier García‐Pérez, Magdalena Corona, et al.. (2022). Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection. Journal of Clinical Medicine. 11(8). 2137–2137. 2 indexed citations
8.
Díez‐Fuertes, Francisco, María Rosa López‐Huertas, Javier García‐Pérez, et al.. (2022). Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection. Frontiers in Cell and Developmental Biology. 10. 839813–839813. 2 indexed citations
9.
García‐Pérez, Javier, Sara Rodríguez-Mora, Montserrat Torres, et al.. (2021). Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Frontiers in Immunology. 12. 742631–742631. 25 indexed citations
10.
Rodríguez-Mora, Sara, Javier García‐Pérez, Mercedes Bermejo, et al.. (2019). The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection. PLoS Pathogens. 15(8). e1007958–e1007958. 17 indexed citations
11.
Díez‐Fuertes, Francisco, Erick De La Torre Tarazona, Esther Calonge, et al.. (2019). Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals. Clinical Microbiology and Infection. 26(1). 107–114. 3 indexed citations
12.
Díez‐Fuertes, Francisco, Erick De La Torre Tarazona, Esther Calonge, et al.. (2019). Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors. Scientific Reports. 9(1). 14265–14265. 10 indexed citations
13.
Bermejo, Mercedes, María Rosa López‐Huertas, Javier García‐Pérez, et al.. (2016). Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells. Biochemical Pharmacology. 106. 30–45. 46 indexed citations
14.
Martı́n, Verónica, Celia Perales, Helena G. Dos Santos, et al.. (2016). An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies. PLoS ONE. 11(12). e0166902–e0166902. 4 indexed citations
15.
Coiras, Mayte, Mercedes Bermejo, Benjamin Descours, et al.. (2016). IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle. Cell Reports. 14(9). 2100–2107. 63 indexed citations
16.
Bénureau, Yann, Philippe Colin, Isabelle Staropoli, et al.. (2016). Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins. Journal of Virological Methods. 236. 184–195. 3 indexed citations
17.
Navarro‐González, Juan F., Carmen Mora‐Fernández, & Javier García‐Pérez. (2009). Reviews: Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis. Seminars in Dialysis. 22(1). 37–44. 121 indexed citations
18.
Rullás, Joaquín, Mercedes Bermejo, Javier García‐Pérez, et al.. (2004). Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes. Antiviral Therapy. 9(4). 545–554. 43 indexed citations
19.
Flores‐Martínez, Silvia Esperanza, et al.. (2002). Association analysis of polymorphisms in the interleukin‐4 receptor (alpha) gene with atopic asthma in patients from western Mexico. European Journal of Immunogenetics. 29(5). 375–378. 11 indexed citations
20.
Abad, Marı́a José, et al.. (2002). Screening of South American Plants against Human Immunodeficiency Virus: Preliminary Fractionation of Aqueous Extract from Baccharis trinervis.. Biological and Pharmaceutical Bulletin. 25(9). 1147–1150. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026